Spots Global Cancer Trial Database for Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
Official Title: Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma. Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5ug) or Placebo in the Treatment of Patients With Hepatocellular Carcinoma Not Amenable to Curative Treatment
Study ID: NCT00051532
Conditions
Interventions
Study Description
Brief Summary: The purpose of the study is to determine whether seocalcitol is effective in the treatment of advanced primary liver cancer (hepatocellular carcinoma \[HCC\]).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
E.g. University Health Network Toronto General Hospital (numerous facilities are recruiting in Canada), Toronto, Alberta, Canada
E.g. Notre-Dame de Bon Secours, Service d´Hepato-Gastro-Enterologie (numerous facilities are recruiting in France), Metz, , France
E.g. Osp. Maggiore, Policlinico di Milano (numerous facilities are recruiting in Italy), Milano, , Italy
E.g. Hospital Clinic Provincial de Barcelona (numerous facilities are recruiting in Spain), Barcelona, , Spain
E.g. The University of Edinburgh Royal Infirmary (numerous facilities are recruiting in UK), Edinburgh, , United Kingdom
Contact Details
Name: Hanne Hvidberg, MSc Pharm, PhD
Affiliation: LEO Pharma
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
